Ensign Peak Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Sell |
|
|||||
|
2025
Q1 | $2.21M | Sell |
|
|||||
|
2024
Q4 | $2.98M | Hold |
|
|||||
|
2024
Q3 | $3.18M | Buy |
|
|||||
|
2024
Q2 | $3.25M | Hold |
|
|||||
|
2024
Q1 | $4.26M | Sell |
|
|||||
|
2023
Q4 | $3.75M | Sell |
|
|||||
|
2023
Q3 | $3.94M | Sell |
|
|||||
|
2023
Q2 | $4.27M | Buy |
|
|||||
|
2023
Q1 | $4M | Sell |
|
|||||
|
2022
Q4 | $5.32M | Buy |
|
|||||
|
2022
Q3 | $3.01M | Sell |
|
|||||
|
2022
Q2 | $3.95M | Buy |
|
|||||
|
2022
Q1 | $5.2M | Sell |
|
|||||
|
2021
Q4 | $7.72M | Buy |
|
|||||
|
2021
Q3 | $2.84M | Buy |
|
|||||
|
2021
Q2 | $1.25M | Sell |
|
|||||
|
2021
Q1 | $14.2M | Sell |
|
|||||
|
2020
Q4 | $12.3M | Sell |
|
|||||
|
2020
Q3 | $11.4M | Buy |
|
|||||
|
2020
Q2 | $7.84M | Buy |
|
|||||
|
2020
Q1 | $5.06M | Sell |
|
|||||
|
2019
Q4 | $6.5M | Buy |
|